Efficiency of Chromosome Microarray Analysis Combined with Karyotyping in Fetuses with Abnormal Down Syndrome Screening Results
Serological screening cannot be replaced by prenatal cfDNA screening. CMA, combined with karyotyping, has a high diagnostic value for DS and should be promoted.
Authors
- Andrew Chih Wei Huang (ORCID: https://orcid.org/0000-0001-9794-7302)
- Tian Tian (ORCID: https://orcid.org/0000-0002-1372-7730)
- Kaize Ding
- Yuquan Li (ORCID: https://orcid.org/0000-0003-4556-6887)
- Huiling Zheng (ORCID: https://orcid.org/0000-0002-0974-0270)
Publication Details
- Journal
- Fetal and Pediatric Pathology
- Published
- 2025-04-22
- DOI
- https://doi.org/10.1080/15513815.2025.2493725
- Primary Topic
- Prenatal Screening and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Science and Technology Bureau, Guiyang Municipal Government